Variável Grupo Média Mediana Padrão Desvio Mínimo Máximo Quartil 1º Quartil 3º P-valor
Peso Pré Soro 291,40 284,00 24,10 264,00 345,00 274,00 302,00 0,3368 Glutamina 278,53 281,00 22,24 242,00 312,00 261,50 296,00 SHAM 289,15 299,00 26,83 238,00 325,00 273,50 310,50 Peso Pós Soro 288,93 275,00 31,11 250,00 350,00 267,00 308,00 0,3605 Glutamina 273,47 275,00 23,67 234,00 328,00 259,00 286,00 SHAM 283,26 285,00 23,19 243,00 325,00 271,50 298,00 Delta peso Soro 4,43 2,00 12,55 -13,00 25,00 -6,00 17,00 0,9373 Glutamina 5,07 2,00 24,91 -39,00 42,00 -7,50 24,00 SHAM 5,42 5,00 21,75 -40,00 43,00 -2,50 14,00
95
9 REFERÊNCIAS
1. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001;286(6):944-53.
2. Waitzberg DL, Lotierzo PHP, Duarte AJS, Schronts E, Cerra. F. Imunonutrição. In: Waitzberg DL. Nutrição oral, enteral e parenteral na prática clínica. 3ª Ed, São Paulo: Atheneu; 2000; 1511-38.
3 Wischmeyer PE, Dhaliwal R, McCall M, Ziegler TR, Heyland DK. Parenteral glutamine supplementation in critical illness: a systematic review. Crit Care. 2014 Apr 18;18(2) ):R76.
4 Chen QH, Yang Y, He HL, Xie JF, Cai SX, Liu AR, Wang HL, Qiu HB. The effect of glutamine therapy on outcomes in critically ill patients: a meta- analysis of randomized controlled trials. Crit Care. 2014;18(1):R8.
5 Heyland DK, Elke G, Cook D, Berger MM, Wischmeyer PE, Albert M, et al; on behalf of the Canadian Critical Care Trials Group. Glutamine and antioxidants in the critically Ill patient: a post hoc analysis of a large-scale randomized trial. JPEN J Parenter Enteral Nutr. 2014;39(4):401-9.
6 Heyland DK, Muscedere J, Wischmeyer PE, Cook D, Jones G, et al; Canadian Critical Care Trials Group. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368(16):1489-97. 7 Dechelotte P, Hasselman M, Cynober L, Allaouchiche B, Coëffier M,
Hecketsweiler B, et al. L-Alanyl-L-glutamine dipeptide-supplemented total parental nutrition reduces infectious complications and glucose intolerance in critically ill patients. The French controlled, randomized, double-blind, multicentre study. Crit Care Med. 2006;34(3):598-604.
8 Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P; Canadian Critical Care Clinical Practice Guidelines Committee. Canadian Critical Care Clinical Practice Guidelines. JPEN J Parenter Enteral Nutr. 2003;27(5):355-73
9 Berg A, Rooyackers O, Norberg A, Wernerman J. Eliminations kinetics of L-alanyl-L-glutamine in ICU patients. Amino Acids. 2005;29(3):221-8. 10 Melis GC, Boelens PG, Van Der Sijp JRM, Popovici T, De Bandt JP,
Cynober L, et al. The feeding route (enteral or parenteral) affects the plasma response of the dipetide Ala-Gln and the amino acids glutamine, citrulline and arginine, with the administration of Ala-Gln in preoperative patients. Br J Nutr. 2005;94(1):19-26.
96
11 Mori M, Rooyackers O, Smedberg M, Tjader I, Norberg A, Wernerman J. Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation. Critical Care. 2014;18(2):R72. 12 Griffiths RD, Allen KD, Andrews FJ, Jones C. Infection, multiple organ
failure, and survival in the intensive care unit: influence of glutamine- supplemented parenteral nutrition on acquired infection. Nutrition. 2002;18(7-8):546-52.
13 Newsholme EA, Crabtree B, Ardawi MS. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q J Exp Physiol. 1985;70(4):473-89.
14 Singleton KD, Wischmeyer PE. Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Physiol. 2007;292(5):R1839-45.
15 Schafer C, Williams JA. Stress kinases and heat shock proteins in the pancreas: possible roles in normal function and disease. J Gastroenterol. 2000;35(1):1-9.
16 Jordan I, Balaguer M, Esteban ME, Cambra FJ, Felipe A, Hernández L,
Alsina L, Molero M, Villaronga M, Esteban E. Glutamine effects on heat shock protein 70 and interleukines 6 and 10: Randomized trial of glutamine supplementation versus standard parenteral nutrition in critically ill children. Clin Nutr. 2015 Feb 7.
17 Yang J, Zhang Y, Zhao S, Zhang Z, Tong X, Wei F, Lu Z. Heat shock protein 70 induction by glutamine increases the α‑ synuclein degradation in SHSY5Y neuroblastoma cells. Mol Med Rep. 2015 Jul 2.
18 Singleton KD, Wischmeyer PE. Effects of HSP70 gene knockout on acute respiratory distress syndrome and the inflammatory response following sepsis. Am J Physiol Lung Cell Mol Physiol. 2006;290(5):L956-61.
19 Saluja A, Dudeja V. Heat shock proteins in pancreatic diseases. J Gastroenterol Hepatol. 2008;23(Suppl 1):S42-5.
20 Zheng YM, Li F, Zhang MM, Wu XT. Glutamine dipeptide for parenteral nutrition in abdominal surgery: a meta-analysis of randomized controlled trials. World J Gastroenterol. 2006;14;12(46):7537-41.
21 Weitzel LR, Wischmeyer PE. Glutamine in critical illness: the time has come, the time is now. Crit Care Clin Nutr. 2010;26(3):515-25.
22 Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 1993;(5):586-90.
97
23 Brivet FG. Scoring systems and severe acute pancreatitis. Crit Care Med. 2000; 28(8):3124-5.
24 Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut. 2000;47(4):546-52.
25 Rakonczay Z Jr., Hegyi P, Takacs T, McCarroll J, Saluja AK. The role of NF-kappaB activation in the pathogenesis of acute pancreatitis. Gut. 2008; 57(2):259-67.
26 Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-83.
27 Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg. 1998;175(1):76-83.
28 Souza LJ, Sampietre SN, Figueiredo S, Yria Y, Machado MC, Pinotti HW. Translocação bacteriana na pancreatite aguda. Estudo experimental em ratos. Rev Hosp Clin Fac Med S Paulo. 1996;51(4):116-20.
29 Souza LJ, Sampietre SN, Assis RS, Knowles CH, Leite KR, Jancar S, et al. Effect of platelet-activating antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. J Gastrointest Surg. 2001;5(4):364-70.
30 Uhl W, Warshaw A, Imrie C, Bassi C, McKay CJ, Lankisch PG, et al. Guidelines for the surgical management of acute pancreatitis. Pancreatology. 2002;2(6):565-73.
31 Wang X, Li W, Li N, Li J. Omega‐3 fatty acids‐supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JPEN J Parenter Enteral Nutr. 2008;32(3):236‐41.
32 Foitzik T, Eibl G, Schneider P, Wenger FA, Jacobi CA, Buhr HJ. Omega-3 fatty acid supplementation increases anti-inflammatory cytokines and attenuates systemic disease sequelae in experimental pancreatitis. JPEN J Parenter Enteral Nutr. 2002;26(6):351-6
33 Xiong J, Zhu S, Zhou Y, Wu H, Wang H. Regulation of ω-3 fish oil emulsion on the sirs during the initial stage of severe acute pancreatitis. J Huazhong Univ Sci Technol. 2009;29(1):35-38.
34 Asrani V, Chang WK, Dong Z, Hardy G, Windsor JA, Petrov MS. Glutamine supplementation in acute pancreatitis: a meta-analysis of randomized controlled trials. Pancreatology. 2013;13(5):468-74.
35 Zhong X, Liang CP, Gong S. Intravenous glutamine for severe acute pancreatitis: a meta-analysis. World J Crit Care Med. 2013 Feb 4;2(1):4-8.
98
36 Gianotti L, Meier R, Lobo DN, Bassi C, Dejong CH, Ockenga J, Irtun O, MacFie J; ESPEN Guidelines on Parenteral Nutrition: pancreas. Clin Nutr. 2009;28(4):428-35
37 http://www.criticalcarenutrition.com/docs/CPGs202015/4.1c202 015.pdf
38 Morrison AL, Dinges M, Singleton KD, Odoms K, Wong HR, Wischmeyer PE. Glutamine's protection against cellular injury is dependent on heat shock factor-1. Am J Physiol Cell Physiol. 2006;290(6):C1625-32.
39 Ziegler TR, Ogden LG, Singleton KD, Luo M, Fernandez-Estivariz C, Griffith DP, et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med. 2005;31(8):1079-86.
40 Banerjee AK, Galloway SW, Kingsnorth AN. Experimental model of acute pancreatitis. Br J Surg. 1994;81:1096-103.
41 Rattner DW. Experimental models of acute pancreatitis and their relevance to human disease. Scand J Gastroenterol. 1996;31(Suppl 219):6-9.
42 Lubianskii VG, Nasonov SV. Acute pancreatitis after resection of stomach for low duodenal ulcer. Khirurgiia (Mosk). 2001(3):8-11.
43 Howard TJ, Moore SA, Saxena R, Matthews DE, Schmidt CM, Wiebke EA. Pancreatic duct strictures are a common cause of recurrent pancreatitis after successful management of pancreatic necrosis. Surgery. 2004;136(4):909-16.
44 Lo SS, Wu CW, Shen KH, Hsieh MC, Lui WY. Higher morbidity and mortality after combined total gastrectomy and pancreaticosplenectomy for gastric cancer. World J Surg. 2002;26(6):678-82.
45 Bailey AA, Bourke MJ, Williams SJ, Walsh PR, Murray MA, Lee EY, et al. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Endoscopy. 2008 Apr;40(4):296-301.
46 Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54(4):425-34.
47 Simmons DT, Petersen BT, Gostout CJ, Levy MJ, Topazian MD, Baron TH. Risk of pancreatitis following endoscopically placed large-bore plastic biliary stents with and without biliary sphincterotomy for management of postoperative bile leaks. Surg Endosc. 2008;22(6):1459-63.
48 Disario JA, Freeman ML, Bjorkman DJ, Macmathuna P, Petersen BT, Jaffe PE, et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology. 2004;127(5):1291
99
49 Lima-Gonçalves E, Yamagushi N, Waitzberg DL, Mello Filho GB. Nutrição parenteral em ratos: aspectos técnicos. Acta Cir Bras. 1990;5(1):17-22. 50 Schmidt J, Rattner DW, Lewandrowski R, Compton CC, Mandavilli U,
Knoefel WT, et al. A better model of acute pancreatitis for evaluating in acute pancreatitis. Scand J Gastroenterol. 1992;215(1):44-56.
51 Moretti ALS, Sarmento Rios EC, Soriano FG, Possolo de Souza H, Abatepaulo F, et al. Hypertonic saline increases heat shock proteins 70 and 90 and reduces neutrophil infiltration in lung injury. Pancreas. 2009;38(5):507-14.
52 COBEA - Comissão de Ensino do Colégio Brasileiro de Experimentação em Animais. Manual para Técnicos em Bioterismo. 2a edição, São Paulo; 1996.
53 http://www.harlan.com/products_and_services/research_models_and _services/research_models/lewis_inbred_rat.hl
54 Shaw R, Festing MF, Peers I, Furlong L. Use of factorial designs to optimize animal experiments and reduce animal use. ILAR J. 2002;43(4):223-32.
55 Ferreira LM, Hochman B, Barbosa MVJ. Experimental models in research. Acta Cir Bras. 2005;20(S2):28-34.
56 "Research Animal Models". Charles River. Retrieved 5 August 2012. 57 Lima-Gonçalves E, Yamagushi N, Waitzberg DL, Mello Filho GB. Nutrição
parenteral em ratos: aspectos técnicos. Acta Cir Bras. 1990;5:17-22. 58 Waitzberg DL, Bellinati-Pires R, Yamaguchi N, Massali-Oku S, Salgado
MM, Hypolito IP, et al. Influence of medium- chain triglyceride-based lipid emulsion on rat polymorphonuclear cell functions. Nutrition. 1996;12(2):93-9.
59 Bertevello PL, De Nardi L, Torrinhas RS, Logullo AF, Waitzberg DL. Partial replacement of ω-6 fatty acids with medium-chain triglycerides, but not olive oil, improves colon cytokine response and damage in experimental colitis. JPEN J Parenter Enteral Nutr. 2012;36(4):442-8.
60 Garib R, Garla P, Torrinhas RS, Bertevello PL, Logullo AF, Waitzberg DL. Effects of parenteral fish oil lipid emulsions on colon morphology and cytokine expression after experimental colitis. Nutr Hosp. 2013;28(3):849- 56
61 Campos FG, Waitzberg DL, Habr-Gama A, Logullo AF, Noronha IL, Jancar S, et al. Impact of parenteral n-3 fatty acids on experimental acute colitis. Br J Nutr. 2002;87(S1):S83-8.
100
62 Galizia MS, Alves CC, Tamanaha RB, Torrinhas RS, Leite FC, Neto AH, Gama-Rodrigues J, Waitzberg DL. A new swivel model for parenteral and enteral infusion in rats. J Surg Res. 2005;128(1):3-8.
63 Wischmeyer PE. Glutamine: role in critical illness and ongoing clinical trials. Curr Opin Gastroenterol. 2008 Mar;24(2):190-7
64 Wischmeyer PE. Glutamine: the first clinically relevant pharmacological regulator of heat shock protein expression? Curr Opin Clin Nutr Metab Care. 2006 May;9(3):201-6.
65 Wischmeyer PE. Glutamine: role in gut protection in critical illness. Curr Opin Clin Nutr Metab Care. 2006 Sep;9(5):607-12.
66 Wang X, Wu K, Wang B, Xu X, Xu M, Gong Z. Effects of glutamine on the intestinal failure in rats model of acute necrotizing pancreatitis. Zhonghua Nei Ke Za Zhi. 2001;40(12):815-8.
67 Foitzik T, Kruschewski M, Kroesen AJ, Hotz HG, Eibl G, Buhr HJ. Does glutamine reduce bacterial translocation? A study in two animal models with impaired gut barrier. Int J Colorectal Dis. 1999;14(3):143-9.
68 Kim M, Wischmeyer PE. Glutamine. World Rev Nutr Diet. 2013;105:90-6. 69 Zheng YM, Li F, Zhang MM, Wu XT. Glutamine dipeptide for parenteral
nutrition in abdominal surgery: a meta-analysis of randomized controlled trials. World J Gastroenterol. 2006;12(46):7537-41.
70 http://www.medsafe.govt.nz/profs/datasheet/d/Dipeptiveninf.pdf
71 Xue P1, Deng LH, Xia Q, Zhang ZD, Hu WM, Yang XN, Song B, Huang ZW. Impact of alanyl-glutamine dipeptide on severe acute pancreatitis in early stage. World J Gastroenterol. 2008;14(3):474-8.
72 van Zanten AR, Sztark F, Kaisers UX, Zielmann S, Felbinger TW, Sablotzki AR, et al. High-protein enteral nutrition enriched with immune- modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA. 2014 Aug 6;312(5):514-24.
73 Tao KM, Li XQ, Yang LQ, Yu WF, Lu ZJ, Sun YM, Wu FX. Glutamine supplementation for critically ill adults. Cochrane Database Syst Rev. 2014 Sep 9;9:CD010050.
74 Fadda V, Maratea D, Trippoli S, Messori A. Temporal trend of short-term mortality in severely ill patients receiving parenteral glutamine supplementation. Clin Nutr. 2013;32(3):492-3.
101
75 Fuentes-Orozco C, Cervantes-Guevara G, Muciño-Hernández I, López- Ortega A, Ambriz-González G, Gutiérrez-de-la-Rosa JL, Gómez-Herrera E, Hermosillo-Sandoval JM, González-Ojeda A. L-alanyl-L-glutamine- supplemented parenteral nutrition decreases infectious morbidity rate in patients with severe acute pancreatitis. JPEN J Parenter Enteral Nutr. 2008;32(4):403-11.
76 Jafari T, Feizi A, Askari G, Fallah AA. Parenteral immunonutrition in patients with acute pancreatitis: a systematic review and meta-analysis. Clin Nutr. 2015;34(1):35-43.
77 Kenneth A. Kudsk, MD. Glutamine: more evidence, more promise. JPEN J Parenter Enteral Nutr. 2008;32(4):492-4.
78 Zhong X, Liang CP, Gong S. Intravenous glutamine for severe acute pancreatitis: a meta-analysis .World J Crit Care Med. 2013;2(1):4-8.
79 Sahin H, Mercanligil SM, Inanç N, Ok E. Effects of glutamine-enriched total parenteral nutrition on acute pancreatitis. Eur J Clin Nutr. 2007;61(12):1429-34.
80 Yong L, Lu QP, Liu SH, Fan H. Efficacy of glutamine-enriched nutrition support for patients with severe acute pancreatitis: a meta-analysis. JPEN J Parenter Enteral Nutr. 2015 Feb 5 [Epub ahead of print].
81 Ockenga J, Borchert K, Rifai K, Manns MP, Bischoff SC. Effect of glutamine-enriched total parenteral nutrition in patients with acute pancreatitis. Clin Nutr. 2002 Oct;21(5):409-16.
82 Asrani V, Chang WK, Dong Z, Hardy G, Windsor JA, Petrov MS. Glutamine supplementation in acute pancreatitis: a meta-analysis of randomized controlled trials. Pancreatology. 2013;13(5):468-74.
83 Jeurnink SM, Nijs MM, Prins HA, Greving JP, Siersema PD. Antioxidants as a treatment for acute pancreatitis: a meta-analysis. Pancreatology. 2015;15(3):203-8.
84 Fernandez-Bustamante A, Agazio A, Wilson P, Elkins N, Domaleski L, He Q, Baer KA, et al. Brief glutamine pretreatment increases alveolar macrophage CD163/heme oxygenase-1/p38-MAPK dephosphorylation pathway and decreases capillary damage but not neutrophil recruitment in IL-1/LPS-insufflated rats. PLoS One. 2015 Jul 6;10(7):e0130764.
85 Goldenberg DE, Gordon SR, Gardner TB. Management of acute pancreatitis. Expert Rev Gastroenterol Hepatol. 2014;8(6):687-94.
86 Easler JJ, Mounzer R, Papachristou GI. Pharmacological therapy for acute pancreatitis: where are we now? where are we going? Minerva Gastroenterol Dietol. 2012;58(4):365-76.
102
87 Kambhampati S, Park W, Habtezion A. Pharmacologic therapy for acute pancreatitis. World J Gastroenterol. 2014;20(45):16868-80.
88 Alhan E, Usta A, Türkyılmaz S, Kural BV, Erçin C. Effects of glutamine alone on the acute necrotizing pancreatitis in rats. J Surg Res. 2015;193(1):161-7.
89 Akinosoglou, Charalambos Gogos. Immune-modulating therapy in acute pancreatitis: Fact or fiction. World J Gastroenterol. 2014;20(41):15200-15. 90 Kinnala PJ, Kuttila KT, Grönroos JM, Havia TV, Nevalainen TJ, Niinikoski
JH. Pancreatic tissue perfusion in experimental acute pancreatitis. Eur J Surg. 2001;167(9):689-694.
91 Cuthbertson C.M, Christophi C. Disturbances of the microcirculation in acute pancreatitis. Br J Surg. 2006;93(5):518–30.
92 Zhao G, Zhang JG, Wu HS, Tao J, Qin Q, Deng SC, et al. Effects of different resuscitation fluid on severe acute pancreatitis. World J Gastroenterol. 2013;19(13):2044-52.
93 Klar E, Messmer K, Warshaw AL, Herfarth C. Pancreatic ischaemia in experimental acute pancreatitis: Mechanism, significance and therapy. Br J Surg. 1990;77(11):1205-10.
94 Trikudanathan G, Navaneethan U, Vege SS. Current controversies in fluid resuscitation in acute pancreatitis: a systematic review. Pancreas. 2012;41(6):827-34.
95 Bi Y, Atwal T, Vege SS. Drug therapy for acute pancreatitis. Curr Treat Options Gastroenterol. 2015;13(3):354-68.
96 Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, Slavin J. Inflammatory mediators in acute pancreatitis. J Pathol. 2000;190(2):117- 25.
97 Su KH, Cuthbertson C, Christophi C. Review of experimental animal models of acute pancreatitis. HPB (Oxford). 2006;8(4):264-86.
98 Hyun JJ, Lee HS. Experimental models of pancreatitis. Clin Endosc. 2014;47(3):212-6.
99 Kahl S, Mayer JM. Update on experimental acute pancreatitis. Minerva Gastroenterol Dietol. 2012;58(4):355-63.
100 Wan MH, Huang W, Latawiec D, Jiang K, Booth DM, Elliott V, Mukherjee R, Xia Q. Review of experimental animal models of biliary acute pancreatitis and recent advances in basic research. HPB (Oxford). 2012;14(2):73-81.
103
101 Llimona F, de Lima TM, Moretti AI, Theobaldo M, Jukemura J, Velasco IT, et al. PGC-1α expression is increased in leukocytes in experimental acute pancreatitis. Inflammation. 2014;37(4):1231-9.
102 Almeida JL, Sampietre SN, Mendonça Coelho AM, Trindade Molan NA, Machado MC, et al. Statin pretreatment in experimental acute pancreatitis. JOP. 2008;9(4):431-9.
103 Coelho AM, Jukemura J, Sampietre SN, Martins JO, Molan NA, Patzina RA, et al. Mechanisms of the beneficial effect of hypertonic saline solution in acute pancreatitis. Shock. 2010;34(5):502-7.
104 Schneider L, Jabrailova B, Strobel O, Hackert T, Werner J. Inflammatory profiling of early experimental necrotizing pancreatitis. Life Sci. 2015;126:76-80.
105 Liang HY, Chen T, Wang T, Huang Z, Yan HT, Tang LJ. Time course of intestinal barrier function injury in a sodium taurocholate-induced severe acute pancreatitis in rat model. J Dig Dis. 2014;15(7):386-93.
106 Schmidt J, Lewandrowski K, Fernandez del Castillo C, Mandavilli U, Compton CC, et al. Histopathologic correlates of serum amylase activity in acute experimental pancreatitis. Dig Dis Sci. 1992;37(9):1426-33.
107 Dubick MA, Mar G, Mayer AD, Majumdar AP, McMahon MJ, Geokas MC. Digestive enzymes and protease inhibitors in plasma from patients with acute pancreatitis.Pancreas. 1987;2(2):187-94.
108 Yadav D, Agarwal N, Pitchumoni CS. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol. 2002;97(6):1309-18.
109 Dambrauskas Z, Giese N, Gulbinas A, Giese T, Berberat PO, Pundzius J,
Barauskas G, Friess H. Different profiles of cytokine expression during mild and severe acute pancreatitis. World J Gastroenterol.
2010;16(15):1845-53.
110 Minkov GA, Halacheva KS, Yovtchev YP, Gulubova MV. Pathophysiological mechanisms of acute pancreatitis define inflammatory markers of clinical prognosis. Pancreas. 2015;44(5):713-7.
111 Bentrem DJ, Joehl RJ. Pancreas: healing response in critical illness. Crit Care Med. 2003;31(8 Suppl):S582-9.
112 Fétaud-Lapierre V, Pastor CM, Jorge-Costa M, Hochstrasser DF, Morel DR, Frossard JL, Lescuyer P. Time-course proteomic analysis of taurocholate-induced necrotizing acute pancreatitis. Proteomics. 2013;85:12-27.
104
113 Meyer A, Kubrusly MS, Salemi VM, De Mendonça Coelho AM, Molan NA,
Patzina RA, Machado MC, Mady C, D'Albuquerque LA, Jukemura J. Severe acute pancreatitis: a possible role of intramyocardial cytokine production. JOP. 2014 May 27;15(3):237-42.
114 Yu C, Huang L, Li X, Zhu H, Li Z, Yu X. Spatial and temporal differences of HMGB1 expression in the pancreas of rats with acute pancreatitis. Int J Clin Exp Pathol. 2015 Jun 1;8(6):6928-35.
115 Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol. 2003;171:6164–6172. 116 Clark EC, Patel SD, Chadwick PR, Warhurst G, Curry A, Carlson GL.
Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrate. Gut. 2003;52:224–230.
117 Curley P, Nestor M, Collins K, Saporoschetz I, Mendez M, Mannick JA, Rodrick ML. Decreased interleukin-2 production in murine acute pancreatitis: potential for immunomodulation. Gastroenterology. 1996;110(2):583-8.
118 Zhang J. Yin and yang interplay of IFN-gamma in inflammation and autoimmune disease. J Clin Invest. 2007;117(4):871-3.
119 Zou WG, Wang DS, Lang MF, Jin DY, Xu DH, Zheng ZC, Wu ZH and Liu XY. Human interleukin 10 gene therapy decreases the severity and mortality of lethal pancreatitis in rats. J Surg Res. 2002; 103: 121-126. 120 Villoria A, Abadía de Barbará C, Molero X, Álvarez A, Antolín M, Guarner
L, Malagelada JR. Early treatment with interleukin-10 (IL-10) in severe acute pancreatitis. Pancreatology. 2003;3:457-81.
121 Devière J, Le Moine O, Van Laethem JL, Eisendrath P, Ghilain A, Severs N, Cohard M. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology. 2001;120:498-505.
122 Dumot JA, Conwell DL, Zuccaro G, Vargo JJ, Shay SS, Easley KA, Ponsky JL. A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol. 2001;96:2098-102.
123 Singh P, Lee T, Davidoff S, Bank S. Efficacy of Interleukin 10 (IL10) in the prevention of post-ERCP pancreatitis: a meta-analysis. Gastrointest Endosc. 2002;55:AB150.
124 Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24:1125–8
105
125 Amanvermez R, Özbalci GS. Clinics related to acute pancreatitis wonder whether IFN- can attenuate pancreatic injury or not. Bosn J Basic Med Sci. 2013;13:203.
126 Meng H, Gong J, Fang L, Song Z, Wu F, Zhou B, Qian M. Effect of interferon- on NF-κB and cytokine IL-18 and IL-27 in acute pancreatitis. Bosn J Basic Med Sci. 2013;13:114-8.
127 Hayashi T, Ishida Y, Kimura A, Iwakura Y, Mukaida N, Kondo T.IFN- protects cerulein-induced acute pancreatitis by repressing NF-κB activation. J Immunol. 2007;178:7385-94.
128 Rau BM, Krüger CM, Hasel C, Oliveira V, Rubie C, Beger HG, Schilling MK. Effects of immunosuppressive and immunostimulative treatment on pancreatic injury and mortality in severe acute experimental pancreatitis. Pancreas. 2006;33:174-83
129 Xue H, Slavov D, Wischmeyer PE.Glutamine-mediated dual regulation of heat shock transcription factor-1 activation and expression. J Biol Chem. 2012;287:40400-13
130 Meng K, Liu Q, Dou Y, Huang Q. Prior peritoneal lavage with hot 0.9 % saline induces HSP70 expression and protects against cerulein- inducedacute pancreatitis in rats. Mol Biol Rep. 2013;40(2):1443-9.
131 Matheus AS, Coelho AM, Sampietre S, Patzina R, Jukemura J, Cunha JE, Machado MC. Effect of inhibition of prostaglandin E2 production on pancreatic infection in experimental acute pancreatitis. HPB. 2007;9(5):392-7.
10 APÊNDICES
APÊNDICE A - apresentação nacional e internacional do estudo
Congresso Americano: Apresentação de dois pôsteres no congresso da Sociedade Americana de Nutrição Clínica e Metabólica - ASPEN, realizado em Fênix – Arizona em Fevereiro de 2013.
Poster 1) "Impact of prior use of parenteral omega-3 fatty acids and glutamine isolated and combined on survival in an experimental model of acute pancreatitis"
Pôster 2) "Impact of prior use of parenteral omega-3 fatty acids and glutamine isolated and combined in inflammatory response in an experimental model of Acute Pancreatitis”
Congresso Brasileiro: Apresentação oral de destaque científico do trabalho “Efeito da infusão parenteral combinada de ácidos graxos ômega-3 e glutamina sobre sobrevida e estresse oxidativo em pancreatite aguda, estudo experimental”.
Congresso Europeu: Apresentação de dois pôsteres no congresso da Sociedade Europeia de Nutrição Clínica e Metabólica – ESPEN, realizado em